AnHorn Medicines Co. Ltd.
- Biotech or pharma, therapeutic R&D
AnHorn Medicines is a clinical-stage biotechnology company dedicated to revolutionizing drug discovery through AI-powered innovation.
AnHorn Medicines spearheads protein degradation innovation, pioneering novel therapeutics to tackle previously unaddressed proteins. Powered by AI, our drug discovery platform facilitates the creation of protein degraders, including PROTACs and molecular glues, leveraging cellular machinery to dismantle disease-causing proteins. This precise approach offers a promising alternative to traditional inhibitors.
AH-001 is the company’s first leading program through its AI-driven platform, exemplifying its mission to create breakthrough therapies that improve patient outcomes.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}